Compare Dolby Laboratories, Inc. (DLB) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs GeneDx Holdings Corp — how do they compare? Dolby Laboratories, Inc. trades at $60.9 (market cap $5.75B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: Dolby Laboratories, Inc. is far larger — about 2.4× GeneDx Holdings Corp's market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| DLB | WGS | |
|---|---|---|
Market Cap | $5.75B | $2.44B |
Sector | Industrials | Technology |
52-Week High | $75.62 | $167.51 |
52-Week Low | $48.51 | $34.51 |
Enterprise Value | $5.12B | $2.48B |
Dividend Yield | 2.35% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
